Patent directory · USPTO A61K / A61P
Patents matching “BOARD OF REGENTS”
2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11753655
Compositions and methods for treatment of neurological disorders
granted -
US 11752221
Brush-arm star polymer imaging agents and uses thereof
granted -
US 11744926
Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
granted -
US 11746152
Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated PD-L1
granted -
US 11738119
Antimicrobial catheters
granted -
US 11738116
Expanded nanofiber structures comprising electrospun nanofibers and a plurality of holes and methods of making and use thereof
granted -
US 11738053
Methods and compositions for treating chronic granulomatous disease
granted -
US 11730717
Melanin-inspired antimicrobial
granted -
US 11730801
Live attenuated Zika virus with 3'UTR deletion, vaccine containing and use thereof
granted -
US 11723992
Method for extraction and purification of 68GA
granted -
US 11723635
Devices and methods for umbilical cord processing
granted -
US 11725008
Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases
granted -
US 11723864
Antimicrobial and anti-inflammatory compositions
granted -
US 11723990
Library of pH responsive polymers and nanoprobes thereof
granted -
US 11718589
Compositions and methods of modulating short-chain dehydrogenase
granted -
US 11717542
Using tumor-navigating Salmonella to modulate tumor metabolism
granted -
US 11718612
Inhibitors of receptor interacting protein kinase I for the treatment of disease
granted -
US 11717573
Methods and compositions for the treatment of cancer
granted -
US 11713313
GLS1 inhibitors for treating disease
granted -
US 11713305
Zinc sensors for in vivo imaging of beta-cell function by MRI
granted -
US 11712467
Methods of rational nicotine hapten design and uses thereof
granted -
US 11696950
Dry solid aluminum adjuvant-containing vaccines and related methods thereof
granted -
US 11696933
HLA-restricted VCX/Y peptides and T cell receptors and use thereof
granted -
US 11690851
Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer
granted